In this interview, we speak to representatives of Axol Bioscience about their human iPSC-derived cells and how they have the potential to revolutionize the field of neurodegenerative disease.

Tissue-specific “adult” stem cells that are capable of both self-renewal and specialized tissue repair reside in certain tissues, such as the epidermis, limbal tissue of the eye, skeletal ...

RxCell has announced a US patent for its induced pluripotent stem cells (iPSCs)-based cell therapy approach, a method of generating multiple cellular therapy products from a single source of iPSCs ...

Cellistic’s Pulse™ Cell Line and Echo™ Cell Therapy Manufacturing platforms are built on induced pluripotent stem cell (iPSC) technology which is the most robust and cost-effective way to ...

iPSC-derived NK cell therapy represents a further therapeutic avenue, leveraging NK cells’ innate ability and iPSCs’ unlimited expansion potential. iPSC-NK cells originate from healthy donors ...

The study highlights the therapeutic success of Qihan’s off-the-shelf, dual-targeting iPSC-derived CAR-NK cell product, QN-139b, in treating refractory systemic sclerosis (SSc).

Collaboration leverages Ginkgo's cell engineering and screening platform to enhance the potency and persistence of Universal Cells' iPSC-derived immune cell therapeutics BOSTON, Jan. 13, 2025 ...

Learn how ioCells can be used in complex cell models to study neurodegeneration Human iPSC-Based Models of Glial Cells for Studying Neurodegenerative Disease Glial cells — encompassing astrocytes, ...

HAMBURG, GERMANY, AND TORONTO, ON/ ACCESSWIRE/ April 2, 2020/ Evotec SE and the innovative biotechnology company panCELLa Inc. announced today that the companies have entered into a licensing and ...

4.6 First iPSC-RPE Cell Sheet Transplantation for AMD, 2014 4.7 EBiSC Founded, 2014 4.8 First Clinical Trial using Allogeneic iPSCs for AMD, 2017 ...

Organ transplantation has been a life-saving treatment for patients with organ failure, but it faces significant challenges ...